Antenatal dexamethasone therapy does not affect circulating concentrations of insulin-like growth factor binding protein-1

Human Reproduction

Volumn 13, Issue 6, 1998, Pages 1714-1716

  Ogueh, O ^a   Hills, F A ^b   Chard, T ^b   Johnson, M R ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Decidua; Dexamethasone; Insulin like growth factor binding protein 1

Indexed keywords

DEXAMETHASONE; SOMATOMEDIN BINDING PROTEIN;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM; FEMALE; FETUS LUNG MATURATION; GESTATIONAL AGE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; PREMATURE LABOR; PRENATAL PERIOD; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS;

ANIMALIA;

EID: 0031861656     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.6.1714     Document Type: Article

References (24)

1. Baxter, R.C. and Cowell, C.T. (1987) Diurnal rhythm of growth hormone-independent binding protein for insulin-like growth factors in human plasma. J. Clin. Endocrinol. Metab., 65, 432-440.
2. Bell, S.C. (1989) Decidualization and insulin-like growth factor (IGF) binding protein: implications for its role in stromal cell differentiation and the decidual cell in haemochorial placentation. Hum. Reprod., 4, 125-130.
3. Crowley, P. (1995) Antenatal corticosteroid therapy: a meta-analysis of randomised trials, 1972-94. Am. J. Obstet. Gynecol., 173, 322-335.
4. Fant, M., Munro, H. and Moses, A.C. (1986) An autocrine/paracrine role for insulin-like growth factors in the regulation of human placental growth. J. Clin. Endocrinol. Metab., 63, 499-505.
5. Hills, F.A., English, J. and Chard, T. (1996) Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J. Endocrinol., 148, 303-309.
6. Holly, J.M.P., Biddlecombe, R.A., Dunger D.B. el al. (1988) Orcadian variation of GH-dependent IGF-binding protein in diabetes mellitus and its relationship to insulin. Clin. Endocrinol., 29, 667-675.
7. Hossenlopp, P., Seurin, D., Segovia, B. et al. (1987) Heterogeneity of insulin-like growth factor binding proteins between structure and affinity. 2. Forms released by human and rat liver in culture. Eur. J. Biochem., 170, 133-142.
8. Jones, J.L., D'Ercole, J., Carnacho-Hubner, C. et al. (1991) Phosphorylation of IGFBP-1 in cell culture and in vivo effects on affinity for IGF-1. Proc. Natl. Acad. Sci. USA, 88, 7481-7485.
9. Jones, J.L., Busby, W.H., Wright, G. et al. (1993) Human IGFBP-1 is phosphorylated on three serine residues: effects of site directed mutagenesis of the major phosphoserine. Growth Regul., 1, 37-40.
10. Lamont, R.F., Dunlop, P.D., Levene, M.I. et al. (1983) Use of glucocorticoids in pregnancies complicated by severe hypertension and proteinuria. Br. J. Obstet. Gynaecol., 90, 199-202.
11. Lewitt, M.S. and Baxter, R.C. (1989) Regulation of growth hormoneindependent insulin-like growth factor-binding protein (BP-28) in cultured human fetal liver expiants. J. Clin. Endocrinol. Metab., 69, 246-252.
12. Liggins, G.C. and Howie, R.N. (1972) A controlled trial of antepartum glucocorticoid treatment for prevention of respiratory distress syndrome in premature infants. Paediatrics, 50, 515-525.
13. Luo, J., Reid, R.E. and Murphy, L.J. (1990) Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-J concentrations in the rat. Endocrinology, 127, 1456-1462.
14. Miell, J.P., Taylor, A.M., Jones J. et al. (1993) Effect of dexamethasone on irnmunoreactive and bioreactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers. J. Endocrinol., 136, 525-533.
15. Miell, J.P., Jauniaux, E., Langford, K.S. et al. (1997) Insulin-like growth factor binding protein concentration and post-translational modification in embryological fluid. Mol. Hum. Reprod., 3, 343-349.
16. Ostlund, E., Bang, P., Hagenas, L. et al. (1997) Insulin-like growth factor I in fetal serum obtained by cordocentesis is correlated with intrauterine growth retardation. Hum. Reprod., 12, 840-844.
17. Price, W.A., Stiles, A.D., Moats-Staats, B.M. et al. (1992) Gene expression of insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology, 130, 1424-1432.
18. Rutanen, E.M., Koistinen, R., Wahlstrom, T. et al. (1985) Synthesis of placental protein 12 by human decidua. Endocrinology, 116, 1304-1309.
19. Rutanen, E.M., Pekonen, F. and Makinen, T. (1988) Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action. J. Clin. Endocrinol. Metab., 66, 173-180.
20. Scharf, J., Ramadori, G., Braulke, T. et al. (1996) Synthesis of insulin-like growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulin-like growth factor, and growth hormone. Hepatology, 23, 818-827.
21. Sinclair, J. (1994) Discussion of Crowley's meta-analysis of randomised controlled trials of antenatal corticosteroids for prevention of respiratory distress syndrome. In Report of the Consensus Development Conference on the Effects of Corticosteroids for Fetal Maturation on Perinatal Outcomes. National Institutes of Health, Bethesda, pp. 95-96.
22. Suikkari, A., Koivisto, V.A., Koistinen, R. et al. (1989) Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor binding protein by insulin. J. Clin. Endocrinol. Metab., 68, 135-140.
23. Wang, H.S. and Chard, T. (1992) The role of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in the control of human fetal growth. J. Endocrinol., 132, 11-19.
24. Wang, H.S., Perry, L.A., Kanisius, J. et al. (1991) Purification and assay of insulin-like growth factor-binding protein-1: measurement of circulating levels throughout pregnancy. J. Endocrinol., 128, 161-168.